Concentriq drives the world's pathology
Concentriq is an enterprise pathology platform for all digital pathology data and AI applications. It bridges the gap between anatomic pathology laboratories and life sciences organizations, enabling real-world pathology data to fuel innovation that enhances patient care.
Enabling anatomic pathology laboratories to achieve 100% digitization and deliver faster, more precise results.
Driving efficiency and insight across the drug R&D value chain, from discovery to development.
Accelerate tomorrow’s breakthroughs today
Modern pathology software helps solve R&D’s biggest challenges. Improve data integrity and quality, run more studies and experiments faster and uncover new insights.
Run a modern, more productive lab
Accelerate your shift to 100% digital diagnosis to improve diagnostic quality, increase efficiency and position your lab for future growth.
AI-powered pathology for the modern laboratory
Concentriq delivers an open platform to serve as a hub for running a range of AI applications, including Proscia’s, your company’s own algorithms and a broad partner portfolio.
Concentriq® delivers value. Proscia delivers trust.
The 2024 KLAS Emerging Company Spotlight recognizes Concentriq as a digital pathology software that overcomes diagnostic challenges and improves lab efficiency.
Download your complimentary copy to get more details.
The data to fight cancer is in this image.
We’re helping labs and research centers take advantage of the collaboration, insight, accuracy and time-saving benefits of digital pathology, and accelerating breakthroughs in the fight against cancer. Learn more about our vision for powering this new era of data-driven pathology.
Latest News & Events
Event:
JP Morgan Healthcare Conference
January 13-16, 2025 | San Francisco, CA
Recent developments in AI are rapidly advancing the next novel therapies and diagnostics. Proscia’s leadership team will be attending this premier healthcare conference ready to discuss pathology’s elevated role in the precision medicine paradigm. Meet with us to find out how we power the world’s life sciences leaders to accelerate drug R&D, build novel diagnostics, and reach more patients.
Webinar:
Unlocking The Promise of Foundation Models in Pathology For AI-Driven Drug Discovery & Development
Available On Demand
Proscia and Bioptimus share how foundation models can transform novel AI development in pathology. Our panel reveals practical strategies to unlock the full value of foundation models to enable faster pathology AI development that can impact all stages of drug discovery and development.
Press Release
CB Insights Recognizes Proscia Among Most Promising Digital Health Companies Of 2024 & Top Vendor in Diagnostic Digital Pathology Market Landscapes
Article
The Pathologist: Path Predictions - What’s on the horizon for digital and AI developments in 2025? We ask technology leaders for their forecasts.
Press Release
Owkin And Proscia Expand Access To AI Pre-Screening For Colorectal Cancer Patients. Owkin’s MSIntuit® CRC v2 to be integrated into Concentriq® software platform
Proscia Leads The Way Forward in Digital Pathology
Proscia Leads The Way Forward in Digital Pathology
We’re proud to be recognized for these outstanding achievements as we advance our mission to change the way we fight diseases like cancer.
Fast Company Next Big Things Award celebrates our pioneering AI-enabled Concentriq platform.
CB Insights named Proscia to its Digital Health 50 list of the world’s most innovative private healthcare companies and recognized us as the #1 vendor in its diagnostic digital pathology market landscapes.
Inc. Magazine Best in Business 2024 honors our contributions to healthcare innovation.